Clinical Trials Logo

Intestinal Fistula clinical trials

View clinical trials related to Intestinal Fistula.

Filter by:

NCT ID: NCT06009744 Recruiting - Clinical trials for Enterocutaneous Fistulas

Vitamin C and Zinc in Patients With Enterocutaneous Fistulas.

VITAC
Start date: August 2023
Phase: N/A
Study type: Interventional

Various micronutrients play an important role in the process of closure and recurrence of enterocutaneous fistulas, such as Vitamin C and Zinc. However, there is no specific recommendation on the dose of these nutrients by parenteral route.

NCT ID: NCT05235204 Recruiting - Colovesical Fistula Clinical Trials

Early Foley Catheter Removal After Diverticular Colovesical Fistula Repair

Start date: March 13, 2019
Phase: N/A
Study type: Interventional

Patients undergoing surgical repair of colovesical fistula will have have "early" (post-operative day 3) cystogram and removal of bladder catheter. Outcomes from the "early" group will be compared to historical "late" group data to determine if early bladder catheter removal is safe.

NCT ID: NCT05234515 Completed - Clinical trials for Surgical Site Infection

Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure

BUGS-IN-IF
Start date: January 14, 2022
Phase:
Study type: Observational

This is a prospective observational study of patients undergoing planned surgery for intestinal failure. The aims of the study are: - To prospectively characterise preoperative bacterial populations amongst patients undergoing surgery for intestinal failure - To examine the relationship between preoperative bacteriology and surgical site infection (SSI) in this patient group - To investigate the effect of surgery and surgical site infection on generic and wound specific quality of life measures

NCT ID: NCT04577456 Recruiting - Ileostomy - Stoma Clinical Trials

Chyme Reinfusion for Type 2 Intestinal Failure

REINFUSE
Start date: October 15, 2022
Phase: N/A
Study type: Interventional

This project aims to introduce and evaluate a novel assistive prosthetic system that helps prevent and treat nutrient and fluid loss from enterocutaneous fistulas. The device system functions simply to return the output from a fistula back into the distal limb of the intestine.

NCT ID: NCT04180735 Completed - Clinical trials for Liver Transplantation

Intestinal Perforation in Patients Receiving an Orthtopic Liver Transplantation in the Montpellier University Hospital

Perfogreffe
Start date: September 30, 2019
Phase:
Study type: Observational

Liver transplantation enhances the prognosis of patients with cirrhoses or hepatocellular carcinoma. However some patients develop intestinal perforations for which the prognosis is poor. The aim of the study is to evaluate the risk factors of intestinal perforations using a retrospective study scheme.

NCT ID: NCT03888976 Completed - Clinical trials for Gallbladder Diseases

Cholecystoduodenal Fistula With and Without Gallstone Ileus

Start date: February 1, 2019
Phase:
Study type: Observational

Observative and descriptive study of 10 patients, which were diagnosed with a Cholecystoduodenal fistula, All electronic medical records were retrospectively reviewed.

NCT ID: NCT03792360 Withdrawn - Clinical trials for Tracheoesophageal Fistula

Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae

Start date: February 2021
Phase: Phase 1
Study type: Interventional

Determine safety and feasibility of using institutionally prepared autologous, uncultured SVF on patients with aerodigestive and enterocutaneous fistulae secondary to malignancy, trauma or surgery.

NCT ID: NCT03773237 Active, not recruiting - Crohn Disease Clinical Trials

Intralipid Versus SMOFlipid in HPN Patients

Start date: December 31, 2018
Phase: N/A
Study type: Interventional

This study will randomize all patients who are new to the Mayo Clinic HPN team to either standard lipid emulsion (Intralipid) or SMOFLipid.

NCT ID: NCT03525756 Completed - Colovesical Fistula Clinical Trials

Cystogram Before Removal of Foley Catheter After Repair of Colovesical Fistula

Start date: December 1, 2017
Phase:
Study type: Observational

Colovesical fistulas are well-recognized but relatively uncommon pathology to both the general and colorectal surgeon. It is a complication arising from an underlying primary acute to chronic inflammatory process. Although colovesical fistulas are uncommon, they are associated with significant morbidity, affect quality of life, and may lead to death, usually secondary to urosepsis. Early diagnosis and management is essential. The purpose of the study is to determine the objective use of cystographic evaluation on postoperative day two to guide early Foley catheter removal post colovesical fistula takedown. The hypothesis is that a cystogram showing no extravasation of contrast on postoperative day two will predict safe removal without increased morbidity. This is an uncontrolled, single arm trial. Patients who meet criteria to undergo either minimally invasive or open colovesical fistula takedown with sigmoid colectomy, without evidence of the need for bladder repair will be eligible to participate. An indwelling Foley catheter is placed intraoperative and continued postoperative. All patients who consent to participate would undergo a cystogram on postoperative day two. The cystogram will be conducted by a radiologist and technician well-trained in the techniques and interpretation of the study. The colorectal surgery enhanced recovery protocol will be followed on all patients with the exception of the cystogram being conducted on post-op day two. If there is no evidence of extravasation of dye is seen on the cystogram the Foley catheter will be removed. Patients will be monitored closely following catheter removal to ensure self-diuresis.

NCT ID: NCT03302598 Completed - Clinical trials for Enterocutaneous Fistula

Assessment of Relation Between Recurrence of Enterocutaneous Fistula and Preoperative C-reactive Protein Level After Complete Surgical Repair

Start date: January 20, 2015
Phase: N/A
Study type: Interventional

A prospective study of 40 patients admitted with the diagnosis of enterocutaneous fistula and prepared for definite surgical repair in the form of resection anastomosis of ECF. The investigators used preoperative serum C-reactive protein as predicting factor to recurrence and independent variable for timing of surgery.